Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug Administration over the agency's decision that Lilly's blockbuster weight-loss and diabetes drugs are no longer in short supply.

For a long time, dieting and exercise were the only realistic options for many people who wanted to lose weight, but recent pharmaceutical advances have led to the development of weight loss drugs. These are based on natural hormones from the intestine that help control food intake,

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls significantly when they learn that the weight might come back when the meds are stopped.

GLP-1 drugs are driving down grocery spending, according to a new study from Cornell’s SC Johnson College of Business and consumer data firm Numerator.The study, which analyzed U.S. household transaction data over two years,

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests they may have surprising mental health benefits.

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug spending. But thus far, the data don’t show this.